Lundbeck

5 minutes with — Lundbeck CEO Dr. Deborah Dunsire
5 minutes with — Lundbeck CEO Dr. Deborah Dunsire
Pharma Voice
Lundbeck
Pharma CEOs
Deborah Dunsire
Flag link:
Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record
Lundbeck replaces retiring CEO Deborah Dunsire with UCB exec after breaking sales record
Fierce Pharma
Lundbeck
Pharma CEOs
Deborah Dunshire
Charl van Zyl
Flag link:
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Yahoo/Benzinga
Otsuka
Lundbeck
FDA
Rexulti
Alzheimer's agitation
Flag link:
Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
Otsuka, Lundbeck gain FDA nod for longer-acting version of schizophrenia drug Abilify
Fierce Pharma
Otsuka
Lundbeck
FDA
Abilify
Asimtufii
bipolar disorder
Flag link:
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation
Fierce Pharma
Lundbeck
Otsuka
Rexulti
Alzheimer's disease
FDA
Flag link:
Go or no go? Seagen's Padcev eyes FDA approval
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Flag link:
Otsuka, Lundbeck eye Alzheimer's indication in FDA adcomm for Rexulti label expansion
Otsuka, Lundbeck eye Alzheimer's indication in FDA adcomm for Rexulti label expansion
Endpoints
Otsuka
Lundbeck
Alzheimer's disease
FDA
Rexulti
Alzheimer's disease agitation
Flag link:
Despite recent approvals, significant unmet need remains in Alzheimer’s market
Despite recent approvals, significant unmet need remains in Alzheimer’s market
Clinical Trials Arena
Alzheimer's disease
Biogen
Eisai
Lundbeck
Otsuka
Avanir Pharmaceuticals
Axesome
Aduhelm
Leqembi
Flag link:
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Flag link:
The Top New York Biopharma Companies Hiring Now
The Top New York Biopharma Companies Hiring Now
BioSpace
New York
hirings
Regeneron
Lundbeck
Schrödinger
Flag link:
FDA accepts Otsuka, Lundbeck filing for long-acting schizophrenia drug, teeing up April decision date
FDA accepts Otsuka, Lundbeck filing for long-acting schizophrenia drug, teeing up April decision date
Fierce Pharma
Otsuka
Lundbeck
schizophrenia
FDA
bipolar disorder
Abilify Maintena
Flag link:
Setback at Lundbeck: CGRP migraine drug Vyepti hits expansion snag, but sales still doubled
Setback at Lundbeck: CGRP migraine drug Vyepti hits expansion snag, but sales still doubled
Fierce Pharma
Lundbeck
earnings
migraines
CGRPs
Vyepti
Flag link:
Tracking mental health: Lundbeck partnership debuts US mapping dashboard tool
Tracking mental health: Lundbeck partnership debuts US mapping dashboard tool
Endpoints
Lundbeck
mental health
COVID-19
Flag link:
Amid crowded migraine market, Lundbeck goes its own way
Amid crowded migraine market, Lundbeck goes its own way
Pharmaforum
Lundbeck
migraines
Lu AG09222
Flag link:
Citing migraine drug growth and pandemic, Lundbeck to cut 300 jobs and close India facility
Citing migraine drug growth and pandemic, Lundbeck to cut 300 jobs and close India facility
Endpoints
Lundbeck
R&D
layoffs
Vyepti
migraines
India
Flag link:
Lundbeck taps Inscopix’ brain-mapping camera tech for CNS research
Lundbeck taps Inscopix’ brain-mapping camera tech for CNS research
Pharmaforum
Lundbeck
Inscopix
CNS
R&D
Flag link:
Lundbeck sells off flopped Alzheimer's drug as Aduhelm approval ups interest
Lundbeck sells off flopped Alzheimer's drug as Aduhelm approval ups interest
Fierce Biotech
Lundbeck
Denovo Biopharma
Alzheimer's disease
Flag link:
2021 Best Places to Work in Medical Sales
2021 Best Places to Work in Medical Sales
MedReps.com
devices
drug reps
Syneos Health
Teleflex
Avion Pharmaceuticals
Acella
Conmed
Acumed
Lundbeck
Amgen
Biogen
Spark Therapeutics
Flag link:
Lundbeck tops Q3 expectations following strong sales of mental health drugs
Lundbeck tops Q3 expectations following strong sales of mental health drugs
Pharmaforum
Lundbeck
earnings
Flag link:
Lundbeck gets cold feet, axes schizophrenia drug trial
Lundbeck gets cold feet, axes schizophrenia drug trial
Pharmaforum
Lundbeck
schizophrenia
clinical trials
Lu AF11167
Flag link:

Pages